Scabies Clinical Trial
Official title:
East Arnhem Healthy Skin Project: A Regional Collaboration to Reduce Scabies, Skin Sores and Associated Chronic Diseases, Including Rheumatic Fever and Renal Disease, Among Australian Aboriginal Communities
The purpose of this study is to determine whether a coordinated regional approach to healthy
skin programs in six remote Aboriginal communities can demonstrate, not only a reduction in
the burden of scabies and streptococcal skin sores, but also broad health benefits,
including primary prevention of some chronic diseases that occur at particularly high rates
in Australian Aboriginal communities.
The primary objectives of the Program are:
- Demonstrate a reduction in scabies and skin sores on a regional basis
- Demonstrate the broader public health effects of Healthy Skin Programs, particularly
those relating to chronic diseases such as rheumatic fever and renal diseases
- Build on the existing Indigenous capacity by assisting in the development of new
knowledge and skills to improve the health and well being of Indigenous communities
- Establish the feasibility of incorporating Healthy Skin Programs into existing health
service delivery
There are standard government recommendations for the conduct of healthy skin programs
within the Northern Territory (NT), where the key component involves a single mass treatment
for scabies of all residents in the region followed by regular monitoring of skin infections
with treatment of individuals as new cases arise. The key features of the guidelines
include:
- Community planning and collaborative effort;
- Development of local educational resources;
- Single whole community treatment day for scabies with permethrin (5%);
- Community "clean up" involving house cleaning, linen and rubbish collection;
- Emphasis on housing functionality and "washing kids" to maintain low rates of skin
sores; and
- Regular monitoring of scabies and skin sores, usually in a target group such as
children
Previous programs have been successful in controlling scabies and related skin infections in
the NT but have been limited to single communities with varying levels of success. In
collaboration with communities in the East Arnhem Region, we propose to conduct a
coordinated Healthy Skin Program. By concentrating on one region, the project has an
increased likelihood of success because reinfection due to mobility between communities will
be minimised, and because the project will be recognised as a collaboration between multiple
communities.
The program is structured into three distinct components:
- Implementation of the program within the participating communities;
- Evaluation of the program against specific outcomes; and
- Integration of the program into routine service delivery.
;
Observational Model: Ecologic or Community, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02572986 -
A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies
|
Phase 3 | |
Completed |
NCT05025696 -
Efficacy and Side Effects of Blacksoap® as Adjuvant Therapy of Scabies
|
N/A | |
Completed |
NCT04205669 -
Comparing the Effectiveness of Individual vs. Household Treatment for Scabies in Lambaréné, Gabon
|
Phase 4 | |
Completed |
NCT02254564 -
PCR (Polymerase Chain Reaction) Assay for Diagnosis of Sarcoptes Scabiei
|
||
Not yet recruiting |
NCT06404333 -
Evaluating Pediatric Ivermectin in Children Under 15 kg (EPIC-15)
|
Phase 2 | |
Completed |
NCT03676140 -
Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )
|
Phase 3 | |
Recruiting |
NCT05875441 -
Efficacy and Safety Study of Moxidectin in Adults With Scabies
|
Phase 2 | |
Completed |
NCT02978508 -
Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies.
|
Phase 3 | |
Recruiting |
NCT04332068 -
Ivermectin Safety in Small Children
|
Phase 2 | |
Recruiting |
NCT04844905 -
Adjunctive Ivermectin Mass Drug Administration for Malaria Control
|
Phase 3 | |
Not yet recruiting |
NCT06380452 -
Therapy for Scabies With Two Differently Concentrated Permethrin Creams
|
Phase 3 | |
Completed |
NCT00604084 -
Veron Scabies Education and Eradication Program
|
N/A | |
Completed |
NCT02485717 -
Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
|
Phase 3 | |
Completed |
NCT02485704 -
Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
|
Phase 3 | |
Recruiting |
NCT05310734 -
PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies
|
Phase 4 | |
Recruiting |
NCT04931680 -
Risk Factors for Treatment Failure of Scabies in Autochthonous Populations of French Guiana (GUYAGALE)
|
||
Completed |
NCT06396507 -
Sulfur vs. Different Regimes of Permethrin for Scabies
|
Phase 3 | |
Completed |
NCT05862701 -
Comparison of Topical 5% Permethrin and Topical 10% Sulfur in the Treatment of Scabies
|
Phase 1 | |
Not yet recruiting |
NCT05500326 -
Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study)
|
Phase 2 | |
Recruiting |
NCT04814511 -
Escalated Therapy of Scabies With INFECTOSCAB 5% (Permethrin)
|
Phase 3 |